Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value per share (DNTH)

77 filings reported holding DNTH - Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value per share as of Q1 2024.
Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value per share (DNTH) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.1M shares of 32.3M outstanding shares and own 80.83% of the company stock.
Largest 10 shareholders include FMR LLC (4.16M shares), Bain Capital Life Sciences Investors, LLC (2.99M shares), Fairmount Funds Management LLC (2.76M shares), Avidity Partners Management LP (2.72M shares), RA CAPITAL MANAGEMENT, L.P. (2.33M shares), VR Adviser, LLC (2.09M shares), Octagon Capital Advisors LP (1.38M shares), 5AM Venture Management, LLC (1.24M shares), RTW INVESTMENTS, LP (667K shares), and GREAT POINT PARTNERS LLC (625K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.